Swiss multicenter study evaluating the efficacy, feasibility and safety of peginterferon-alfa-2a and ribavirin in patients with chronic hepatitis C in official opiate substitution programs.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples